VentriPoint Diagnostics’s (5V7) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting VentriPoint Diagnostics is a Buy.
VentriPoint Diagnostics’s (5V7) 20-Day exponential moving average is 0.04, while VentriPoint Diagnostics’s (5V7) share price is €0.03, making it a Sell.
VentriPoint Diagnostics’s (5V7) 50-Day exponential moving average is 0.04, while VentriPoint Diagnostics’s (5V7) share price is €0.03, making it a Sell.
VentriPoint Diagnostics’s (5V7) 10-Day exponential moving average is 0.03, while VentriPoint Diagnostics’s (5V7) share price is €0.03, making it a Sell.
VentriPoint Diagnostics’s (5V7) 100-Day exponential moving average is 0.05, while VentriPoint Diagnostics’s (5V7) share price is €0.03, making it a Sell.
VentriPoint Diagnostics’s (5V7) stock price is €0.03 and VentriPoint Diagnostics’s (5V7) 50-day simple moving average is 0.04, creating a Sell signal.
VentriPoint Diagnostics’s (5V7) stock price is €0.03 and VentriPoint Diagnostics’s (5V7) 100-day simple moving average is 0.05, creating a Sell signal.
VentriPoint Diagnostics’s (5V7) stock price is €0.03 and VentriPoint Diagnostics’s (5V7) 200-day simple moving average is 0.06, creating a Sell signal.